Cargando…
Yisaipu(®) Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation
Objectives: Anti-tumor necrosis factor (TNF) agents have been regarded as the most effective treatment for ankylosing spondylitis (AS) so far. However, economic factors limited the prescription of original biologicals in China. Yisaipu(®) is a biosimilar for etanercept as pre fill syringes (PFS), wh...
Autores principales: | Lu, Hongjuan, Wang, Yuanqiong, Wang, Xiuwen, Wu, Xin, Zhou, Ling, Lin, Li, Sheng, Rong, Tian, Haoran, Li, Ting, Xu, Huji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450409/ https://www.ncbi.nlm.nih.gov/pubmed/34552481 http://dx.doi.org/10.3389/fphar.2021.692768 |
Ejemplares similares
-
The correlations between C-reactive protein and MRI-detected inflammation in patients with axial spondyloarthritis: a systematic review and meta-analysis
por: Tian, Haoran, et al.
Publicado: (2023) -
Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial
por: Zhao, Dongbao, et al.
Publicado: (2021) -
Brain Activity in Advantageous and Disadvantageous Situations: Implications for Reward/Punishment Sensitivity in Different Situations
por: Dong, Guangheng, et al.
Publicado: (2013) -
Investigating the origin and consequences of endogenous default options in repeated economic choices
por: Couto, Joaquina, et al.
Publicado: (2020) -
Assessment of Neuropathic Pain in Ankylosing Spondylitis: Prevalence and Characteristics
por: Zhou, Ling, et al.
Publicado: (2021)